Journal article
Vascular effects of the human extracellular superoxide dismutase R213G variant
Circulation (New York, N.Y.), Vol.112(7), pp.1047-1053
2005
DOI: 10.1161/CIRCULATIONAHA.104.531251
PMID: 16087794
Abstract
Background— Extracellular superoxide dismutase (ECSOD) is a major extracellular antioxidant enzyme. We have demonstrated that vascular effects of ECSOD require an intact heparin-binding domain. A common genetic variant with a substitution in the heparin-binding domain (ECSODR213G) was reported recently to be associated with ischemic heart disease. The goal of this study was to examine vascular effects of ECSODR213G.
Methods and Results— A recombinant adenovirus (Ad) that expresses ECSODR213G was constructed. ECSODR213G and ECSOD proteins bound to collagen type I in vitro, but binding to aorta ex vivo was 10-fold greater with ECSOD than ECSODR213G. Three days after intravenous injection of AdECSODR213G or AdECSOD in spontaneously hypertensive rats (SHR), immunostaining demonstrated binding of ECSOD to carotid arteries and kidneys but minimal binding of ECSODR213G. Binding to aorta and carotid artery was 2.5- to 3-fold greater with ECSOD than ECSODR213G by immunoblotting. Arterial pressure was significantly reduced by AdECSOD but not by AdECSODR213G. Responses to acetylcholine and basal levels of nitric oxide in carotid arteries were impaired in SHR compared with normotensive Wistar-Kyoto rats and were improved after AdECSOD but not AdECSODR213G. Levels of superoxide and nitrotyrosine in aorta were higher in SHR than Wistar-Kyoto rats and were greatly reduced after AdECSOD but not AdECSODR213G.
Conclusions— In contrast to ECSOD, ECSODR213G has no significant protective effect on arterial pressure, vascular function, or vascular levels of oxidative stress in SHR. These findings may provide a mechanistic basis for association studies that suggest that human beings carrying ECSODR213G are predisposed to vascular diseases.
Details
- Title: Subtitle
- Vascular effects of the human extracellular superoxide dismutase R213G variant
- Creators
- Yi Chu - Cardiovascular Center and Departments of Internal Medicine, University of Iowa, Iowa City, Iowa, United StatesAbdullah ALWAHDANI - Cardiovascular Center and Departments of Internal Medicine, University of Iowa, Iowa City, Iowa, United StatesShinichiro IIDA - Cardiovascular Center and Departments of Internal Medicine, University of Iowa, Iowa City, Iowa, United StatesDonald D LUND - Cardiovascular Center and Departments of Internal Medicine, University of Iowa, Iowa City, Iowa, United StatesFrank M FARACI - Cardiovascular Center and Departments of Internal Medicine, University of Iowa, Iowa City, Iowa, United StatesDonald D HEISTAD - Cardiovascular Center and Departments of Internal Medicine, University of Iowa, Iowa City, Iowa, United States
- Resource Type
- Journal article
- Publication Details
- Circulation (New York, N.Y.), Vol.112(7), pp.1047-1053
- DOI
- 10.1161/CIRCULATIONAHA.104.531251
- PMID
- 16087794
- NLM abbreviation
- Circulation
- ISSN
- 0009-7322
- eISSN
- 1524-4539
- Publisher
- Lippincott Williams & Wilkins; Hagerstown, MD
- Language
- English
- Date published
- 2005
- Academic Unit
- Cardiovascular Medicine; Neuroscience and Pharmacology; Internal Medicine
- Record Identifier
- 9984040203302771
Metrics
17 Record Views